Back to News
Market Impact: 0.2
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Bronstein, Gewirtz & Grossman announced that a securities class-action lawsuit has been filed against Replimune Group (NASDAQ: REPL) and certain company officers. The notice introduces legal and reputational risk for the biotech company, although the announcement provides no details on allegations, damages, or potential financial exposure.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.30
Ticker Sentiment
REPL-0.80
More News
- California AG Says Paramount-WBD Merger Would Hurt the State
- Halozyme prices $1.3 billion convertible notes offering
- Jana Partners pushes Cooper to replace CEO, weigh asset sales- WSJ
- UN fact-finding mission says US committed possible war crimes in Iran
- FDA approves Ultragenyx’s Fayuvi for Sanfilippo syndrome Type A
- Paramount is getting an assist from a key California pol as it defends its Warner merger against AG Rob Bonta